This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Cellesce Limited, Molecular Devices Corporation. Active years: 2022-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2025
Title: The Innovative Contributions of Marianne J Ellis
Introduction
Marianne J Ellis is a prominent inventor based in Cardiff, GB. She has made significant contributions to the field of organoid culture, holding 2 patents that showcase her innovative methods. Her work has implications for various applications in biomedical research and development.
Latest Patents
One of her latest patents is titled "Methods for culturing organoids." This invention provides a method for culturing organoids, which includes disassociating unprocessed organoids to produce a cell suspension. The method further involves sieving the cell suspension through a cell strainer to retain a sieved cell suspension containing cells of about 10 μm to about 1 mm in diameter. Finally, the cells from the sieved cell suspension are seeded into a bioreactor in a cell culture medium that comprises an extracellular support matrix. This innovative approach enhances the efficiency and effectiveness of organoid culture.
Career Highlights
Throughout her career, Marianne has worked with notable companies such as Molecular Devices Corporation and Cellesce Limited. Her experience in these organizations has allowed her to refine her skills and contribute to advancements in organoid technology.
Collaborations
Marianne has collaborated with esteemed colleagues, including Julian Chaudhuri and Trevor Clive Dale. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Marianne J Ellis is a trailblazer in the field of organoid culture, with her patents reflecting her dedication to advancing scientific knowledge. Her contributions continue to influence the landscape of biomedical research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
